CDC Relaxes COVID-19 Vaccination Rules for Foreign Travelers
FRIDAY, April 28, 2023 (HealthDay News) -- Travelers to the United States will now only need a single bivalent COVID-19 vaccine from either Pfizer or Moderna to enter the country, the U.S. Centers for Disease Control and Prevention announced Thursday.
The loosening of vaccination requirements for foreign travelers comes as many other countries have already done so.
"Because some traveler vaccine records might not specify whether recent Moderna or Pfizer doses received were bivalent, CDC will consider anybody with record of a single dose of Moderna or Pfizer vaccine issued on or after August 16, 2022, to meet the requirements," because that was when bivalent vaccines first became available, the agency said in an update to its website.
Earlier this month, the CDC and the U.S. Food and Drug Administration changed the vaccine schedule so that unvaccinated Americans could be considered fully vaccinated with just one dose of bivalent vaccine instead of the earlier versions, CBS News reported. Another federal agency, the U.S. Centers for Medicare & Medicaid Services, announced that health care workers would be considered "fully vaccinated" with the one bivalent dose.
Travel industry officials have said they expected the vaccination requirement to be allowed to expire altogether, CBS News reported. At this point, the Transportation Security Administration has renewed the requirement through May 11.
A spokesperson for the Department of Health and Human Services said there was no update on the requirement, CBS News reported.
Related Posts
Health Highlights, Nov. 5, 2021
New pill shows great promise in fighting COVID-19. An experimental pill reduced...
1998 to 2022 Saw Rise in Number Seeking Assisted Death in Oregon
FRIDAY, Oct. 6, 2023 (HealthDay News) -- Over the 25 years that Oregon has...
Tobacco Dependence Greater for Cigarette-Dominant Tobacco Users
THURSDAY, July 27, 2023 (HealthDay News) -- Cigarette-dominant tobacco users...
Prescriptions Rise for Veterinary Drug for COVID-19 Patients
MONDAY, Aug. 30, 2021 (HealthDay News) -- Despite studies showing that it does...